[Cordio Medical in EIN Newswires] Cordio Medical presents study validating voice signature AI tool that monitors congestive heart failure
NEW YORK, NEW YORK, UNITED STATES, November 14, 2023 /EINPresswire.com/ — Cordio Medical, developer of the HearO® app, presented the positive results from their clinical study during the American Heart Association’s Scientific Sessions. The research tested and validated the HearO® app, which combines the first smartphone-based mobile speech application and cloud-based computing to detect changes in Speech Measures (SM) indicative of worsening heart failure. Read...
Read More